Company / Profit Margin
Yubo International Biotech Ltd Profit Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-8736.7%
FY2025
5-year range
-51171.4% / -197.6%
FY2022-FY2025
Trend
+82.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -197.6% to -8736.7% over the past 2 years.
Based on SEC 10-K filings.
-8736.7% in FY2025 with a 3-year CAGR of -7581.2%.
Declined from -197.6% to -8736.7% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -7581.2pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 82.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -8736.7% | +82.9% |
| FY2024 | -51171.4% | -25791.2% |
| FY2023 | -197.6% | +82.9% |
| FY2022 | -1155.5% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |